CardioVascular Center

CardioVascular Center Frankfurt (CVC Frankfurt) is a premier clinical research and medical treatment facility specializing in interventional cardiology and vascular medicine. Led by world-renowned cardiologist Prof. Horst Sievert, the center operates as both a specialized medical practice and a clinical research organization (CRO) that conducts early-feasibility and first-in-human clinical trials for innovative medical devices and pharmacological treatments. CVC Frankfurt is particularly recognized for its leadership in structural heart interventions, including percutaneous PFO closure and transcatheter aortic valve replacement (TAVR). The center collaborates extensively with global medical device and pharmaceutical companies to validate cutting-edge technologies and advance cardiovascular care standards.